Navigation Links
Inverness Medical Innovations Announces Fourth Quarter 2008 Results
Date:2/18/2009

220 257,139 Gross margin 54% 56% Operating expenses: Research and development 25,402 (2,506) (b)(c)(d) 22,896 Purchase of in- process research and development - - - Selling, general and administrative 188,192 (56,579) (b)(c)(d) 131,613 Total operating expenses 213,594 (59,085) 154,509 Operating income 32,325 70,305 102,630 Interest and other income (expense), net (19,205) 147 (c) (19,058) Income tax (benefit) provision (3,412) 28,192 (h) 24,780 Equity earnings of unconsolidated entities, net of tax (119) 1,505 (b)(c) 1,386 Net income (loss) $16,413 $43,765 $60,178 Preferred stock dividends $(5,490) (5,490) Net income (loss) available to common stockholders - basic $10,923 $54,688 Net income (loss) per common share: Basic $0.14 $0.70 Diluted $0.14 (i) $0.66 (k) Weighted average common shares - basic 78,217 78,217 Weighted average common shares - diluted 78,941 (i) 92,853 (k) Three Months Ended December 31, 2007 Non-GAAP Adjusted Non-GAAP Cash
'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 18, 2009 to Discuss Fourth Quarter 2008 Results
2. James Roosevelt, Jr. Joins Inverness Medical Innovations Board of Directors
3. Inverness Medical Innovations to Present at the 2009 UBS Global Healthcare Services Conference on February 10, 2009
4. Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008
5. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009
6. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
7. Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008
8. Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
9. Inverness Medical Innovations to Present at the Third Annual JMP Securities Healthcare Focus Conference on October 7, 2008
10. Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo
11. Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Goodman HealthDay Reporter , , SATURDAY, May 18 ... a better view during colonoscopies may help them miss ... shows. Colonoscopies are the recommended screening tests for ... of men and women in the United States. ... tube with a camera mounted on the end called ...
(Date:5/20/2013)... May 20, 2013 A novel service for ... . The company has been in the field of providing ... will make sure that scholars are able to maintain a ... has three stages and has been priced at $1000. , ... dedicated mentor assigned to the project, who will handle all ...
(Date:5/20/2013)... Hiscall Inc. is pleased to announce the ... devices. The Hiscall app includes past, current and future ... and event alerts. , For many, the mobile ... such as the Hiscall Technology Showcase, enabling users to register ... layout. During and after the event users can access ...
(Date:5/20/2013)... Dana R. Hando knows that nails ... experience in a salon, she has seen nails of different shapes, ... article that explains how this small body part can actually serve ... body. A piece from The Huffington Post explains that ... on early warning signs of medical conditions. , Nails that ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 When developing ... gender and personality, are taken into consideration to help ... Researchers have previously determined that there is a clear ... Doc considers the science behind these studies and others ... Now, a new study exploring the effect weight gain ...
Breaking Medicine News(10 mins):Health News:New Device May Show Doctors More of the Colon 2Health News:New Device May Show Doctors More of the Colon 3Health News:Dissertation Clinic Prescribes Customized Remedy for Researchers 2Health News:According to Dana R. Hando, Nails Help to Illustrate Total Body Health 2Health News:According to Dana R. Hando, Nails Help to Illustrate Total Body Health 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New Improved hCG Diet Helping Patient’s Control Eating Impulses 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New Improved hCG Diet Helping Patient’s Control Eating Impulses 3
... targeted therapy against the BRAF/MAPK pathway with immunotherapy shows ... of melanoma, according to results of a preclinical study ... the American Association for Cancer Research. "Our results ... therapy and immunotherapy in the treatment of this most ...
... Center in Hamburg, Germany successfully used transcatheter valve-in-valve implantation ... mitral position. This minimally invasive procedure was used ... at high surgical risk. Full details of the ... Catheterization and Cardiovascular Interventions , a journal published by ...
... more likely to underestimate their preschool children,s weight when ... or gaining weight too fast, a study by the ... The study, published online earlier this ... not hesitate to wield their influence in helping parents ...
... ... holistically reverse symptoms associated with Polycystic Ovarian Syndrome and Insulin Resistance in her e-book. ... (PRWEB) ... are now able to lose weight and achieve hormonal balance without taking any prescription ...
... male-only protein found in rats helps control stress signals in ... -- When it comes to stress, women are twice as ... and/or post-traumatic stress, and now a new study in rats ... evidence in animals that suggests that males benefit from having ...
... Journal of Thoracic Oncology features a study aimed ... nab-paclitaxel with carboplatin as a first-line therapy in patients ... researchers with a data needed to guide a phase ... for patients with NSCLC is carboplatin plus solvent-based paclitaxel. ...
Cached Medicine News:Health News:Combined BRAF-targeted and immunotherapy shows promise for melanoma treatment 2Health News:Elderly patients in need of heart valve replacements have alternative to surgery 2Health News:Pediatricians can help parents recognize overweight preschoolers 2Health News:Pediatricians can help parents recognize overweight preschoolers 3Health News:Women with Polycystic Ovarian Syndrome and Insulin Resistance can Lose Weight and Balance Hormones Naturally with Katie Humphrey's New E-book 2Health News:Females May Be Naturally More Prone to Stress: Animal Study 2Health News:Novel paclitaxel formulation encouraging for treating advanced lung cancer 2
(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will ... March 31, 2013, before market on Tuesday, May 28, 2013.  ... 28, 2013, at 8:00 a.m. EDT (May 28, 2013 at ... results and provide an update on recent corporate developments. ...
(Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...
(Date:5/16/2013)...  PTC Therapeutics, Inc., today announced that it has ... U.S. Securities and Exchange Commission ("SEC") relating to the ... number of shares to be offered and the price ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) J.P. ... managers for the offering. Cowen and Company is acting ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... Mich., Jan. 23, 2012 Perrigo Company (Nasdaq: PRGO;TASE) announced ... Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine ... the owner of the New Drug Application (NDA) of its ... Impax Laboratories, Inc. (Nasdaq: IPXL ), who will ...
... (OTC: PLCSF), a company focused on innovative medical device ... in the CIN-RG trial, the company,s pivotal trial to ... System™ in the prevention of Contrast-Induced Nephropathy (CIN).  This ... regulatory approval by the U.S. Food and Drug Administration ...
Cached Medicine Technology:Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals 2Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals 3First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 2First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 3
... provides anterior column support for single or ... to L5. The system consists of one ... that are stacked to a desired height, ... Fiber Reinforced Polymer material emulates the biomechanical ...
... in interbody fusion are to ... restore disc space height and ... an enviroment for bone fusion ... Allograft is designed to promote ...
... highly adaptable and therefore suitable for a ... its extraordinary small outer diameter and the ... a simple but secure and reliable fixation ... instruments around the corner. These characteristics make ...
A new flexible endoscope with an ultra dense optic fiber system. Its two working and irrigation channels and steering mechanism makes it ideal for a multipurpose use in neurosurgical endoscopy i.e. V...
Medicine Products: